New heart procedure aims to zap away AFib with less risk

NCT ID NCT06676072

Ongoing Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated May 16, 2026 · Updated 17 times

Summary

This study tests a new device (TactiFlex SE catheter and Volt generator) that uses pulsed field ablation to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. About 188 people with symptomatic AFib that hasn't responded to medication will receive the procedure. The goal is to see if the treatment is safe and effectively stops AFib episodes for at least 30 seconds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

AdventHealth Orlando

Orlando, Florida, 32803, United States
Arkansas Heart Hospital

Little Rock, Arkansas, 72211, United States
Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Bryan Heart Medical Center

Lincoln, Nebraska, 68506, United States
Duke University Medical Center

Durham, North Carolina, 27705, United States
Erasmus Medical Center - Thoraxcenter

Rotterdam, S Holln, 3015 CE, Netherlands
HCA Florida Mercy Hospital

Miami, Florida, 33133, United States
Henry Ford Providence Southfield Hospital

Southfield, Michigan, 48075, United States
HonorHealth

Scottsdale, Arizona, 85258, United States
Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
Houston Methodist The Woodlands Hospital

Shenandoah, Texas, 77385, United States
KH Wiener Neustadt

Wiener Neustadt, L Austr, 2700, Austria
Kansas City Cardiac Arrhythmia Research Foundation

Overland Park, Kansas, 66211, United States
Loyola University Medical Center

Maywood, Illinois, 60153, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Medical City Fort Worth

Fort Worth, Texas, 76104, United States
NYU Langone Health

New York, New York, 10016, United States
New York Presbyterian Hospital/Cornell University

New York, New York, 10021, United States
Ocelot Medical Research Group

Dallas, Texas, 75230, United States
Piedmont Athens Regional Medical Center

Athens, Georgia, 30606, United States
South Denver Cardiology Associates PC

Littleton, Colorado, 80120, United States
Stanford University Medical Center

Stanford, California, 94305, United States
Tallahassee Research Institute

Tallahassee, Florida, 32308, United States
Texas Cardiac Arrhythmia

Austin, Texas, 78705, United States
The Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States
The Heart Institute at Virginia Mason

Seattle, Washington, 98111, United States
The Heart Rhythm Center of MS

Gulfport, Mississippi, 39501, United States
Tristar Centennial Medical Center

Nashville, Tennessee, 37203, United States
University of Michigan Medical Center

Ann Arbor, Michigan, 48104, United States
Vanderbilt Heart & Vascular Institute

Nashville, Tennessee, 37232, United States
Vilnius University Hospital Santariskiu Klinikos

Vilnius, Dzukija, 08661, Lithuania
Virginia Commonwealth University

Richmond, Virginia, 23219, United States

Conditions

Explore the condition pages connected to this study.

ATRIAL ARRHYTHMIA ATRIAL FIBRILLATION (AF) DRUG REFRACTORY PAROXYSMAL ATRIAL FIBRILLATION PAROXYSMAL AF